Trials / Unknown
UnknownNCT02363101
Health Outcomes and Costs (HOC) in Lung Cancer (LC)
Health Outcomes and Costs (HOC) in Brazilian Public Health Care System - The HOC Study in Lung Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Instituto Nacional de Cancer, Brazil · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the costs, health-related quality of life and preference values from lung cancer patients assisted in a Brazilian public health care unit.
Detailed description
The costs will be assessed by micro-costing approach. All procedures involved in lung cancer at diagnosis, staging, treatment and best supportive care will be assessed. The health-related quality of life will be assessed by EORTC-QLQ-C30, EQ-5D and EORTC-QLQ-LC13 in all different stages of lung cancer. An utility measure will be considered. The preference values will be assessed via discrete choice experiment. Two scenarios will be designed and the lung cancer patients will be asked about the preferences.
Conditions
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-03-01
- Completion
- 2016-12-01
- First posted
- 2015-02-13
- Last updated
- 2015-03-04
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02363101. Inclusion in this directory is not an endorsement.